WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) today announced the recipients of the 2025 Early Career Research Grants (ECRGs), an initiative designed to support the next generation of academic interventional cardiologists. Now in its fourth year, the program provides critical early-stage funding to junior investigators pursuing high-impact research in coronary, peripheral, and structural heart disease.
The 2025 recipients will be formally recognized during a convocation ceremony at SCAI Scientific Sessions 2025, held May 1–3 in Washington, DC. Each recipient will receive one year of research support and present their findings at SCAI Scientific Sessions 2026.
“These grants are an investment in the future of interventional cardiology,” said Ehtisham Mahmud, MD, MSCAI, Chair of the SCAI Scientific Oversight Committee and Past President of SCAI. “They support not only important scientific questions, but the professional growth of emerging physician-scientists. With industry support and a rigorous review process, we’re proud to provide a platform for promising researchers to launch projects that will ultimately improve care for patients worldwide.”
Doosup Shin, MD, FSCAI
Study Title: Use of Alternate Flush Media in the Lower Extremity to Facilitate Optical Coherence Tomography Imaging of the Infrapopliteal Segment
Zaid I. Almarzooq, MBBCH, MPH, FSCAI
Study Title: Lifetime Management of Patient Undergoing Aortic Valve Replacement for Severe Aortic Stenosis: Trends and Outcomes in Low-Risk Surgical Patients
Study Title: In-Stent Restenosis in Contemporary Clinical Practice: An Analysis of Incidence, Risk Factors, Time to Stent Failure, and Variation in Treatment Approaches
Zachary Rosol, MD, FSCAI
Study Title: Comparative Outcomes of Intravascular Lithotripsy Versus Atherectomy Calcium Modification in the Infrapopliteal Arteries from the Multicenter XLPAD Registry
“Early-career researchers face an uphill climb when it comes to securing funding,” said SCAI President James B. Hermiller, MD, MSCAI. “This program is about giving them a boost when they need it most—supporting ideas that are innovative, grounded in clinical relevance, and capable of shaping the future of our field.”
The SCAI Early Career Research Grant program is open to members within ten years of completing an interventional cardiology fellowship. All proposals undergo blinded review by the SCAI Scientific Oversight Committee, which evaluates applications based on significance, innovation, feasibility, and alignment with current clinical priorities.
Unrestricted educational grants from Abbott, Edwards Lifesciences, Medtronic, and Shockwave Medical support these research awards. No in-kind commercial support was received.
Recipients will present the results of their research at a dedicated session during SCAI Scientific Sessions 2026, and are encouraged to submit their findings for publication in JSCAI.
The next ECRG application cycle will open in November 2025.
Press Contacts
Gavin Stern
[email protected], 202-644-8561
Annika Parrish
[email protected], 720-412-9042
About SCAI Scientific Sessions 2025
The SCAI Scientific Sessions annual meeting convenes 2,000 of the world’s premier clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. With 500+ faculty and hundreds of abstracts, experts in the field work together to share the latest clinical data, procedural guidance, and advanced expertise. Highlights will include live cases, featured clinical research, new SCAI clinical documents, case-based learning, and keynote speakers. For more information, visit SCAI 2025 Scientific Sessions | SCAI.
About Society for Cardiovascular Angiography & Interventions (SCAI)
The Society for Cardiovascular Angiography & Interventions, established in 1978, stands as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care. For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 5,000 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease. For more information, visit SCAI.ORG.
What's Happening at SCAI
Updates on the Society's publications, advocacy initiatives, fundraising, professional recognition programs, research, and collaborations with partners.